Late Breaking Abstract - Increased adherence to Easyhaler DPI controller treatment with electronic sensor monitoring and mobile patient feedback in adult patients with asthma

<bold>Background:</bold> Controller treatment, foremost inhaled corticosteroids, is the cornerstone of asthma treatment. Yet, adherence to it often remains low. <bold>Objectives:</bold> We studied whether adherence to controller medication can be improved by using Easyhaler DPI (EH) with electronic sensor monitoring and mobile patient feedback (Propeller Health) vs usual care. <bold>Methods:</bold> A randomized, open, phase 4 study in patients with suboptimal asthma control (ACT≤19) was conducted in Germany. In 4-week run-in controller inhaler was switched to EH+sensor with no change in the drug substance. Salbutamol EH+sensor was used as reliever. Patients in intervention group (IG) received reminders on controller medication use, whereas those in usual care group (UCG) didn’t. Primary end point was controller adherence during last 6 weeks of the 6-month study. <bold>Results:</bold> Patients in IG (N=78) had a significantly higher mean weekly adherence to controller treatment (79.7 %) vs CG (N=80) (58.9%) (p<0.001) with 73% of those in IG vs 40% in UCG having adherence of > 80% (p<0.001). Difference emerged in the first month and remained for the rest of the study (Figure 1). Mean weekly reliever use was less in IG vs UCG (0.87 vs 1.93 inhalations, p<0.05). <bold>Conclusions:</bold> Inhaler treatment adherence among patients with asthma may be enhanced by Easyhaler DPI with sensor monitoring and mobile patient feedback. <fig><object-id>erj;64/suppl_68/PA796/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig>

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa796
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Late Breaking Abstract - Increased adherence to Easyhaler DPI controller treatment with electronic sensor monitoring and mobile patient feedback in adult patients with asthma

Thomas Schultz, Margret Jandl, Sabina Wehgartner-Winkler, Mikko Vahteristo et al.
Asthma and respiratory diseases
article

Late Breaking Abstract - Increased adherence to Easyhaler DPI controller treatment with electronic sensor monitoring and mobile patient feedback in adult patients with asthma

Thomas Schultz, Margret Jandl, Sabina Wehgartner-Winkler, Mikko Vahteristo, Athanasios Xanthopoulos, Satu Lähelmä, Michael Sebert
article en

Abstract

<bold>Background:</bold> Controller treatment, foremost inhaled corticosteroids, is the cornerstone of asthma treatment. Yet, adherence to it often remains low. <bold>Objectives:</bold> We studied whether adherence to controller medication can be improved by using Easyhaler DPI (EH) with electronic sensor monitoring and mobile patient feedback (Propeller Health) vs usual care. <bold>Methods:</bold> A randomized, open, phase 4 study in patients with suboptimal asthma control (ACT≤19) was conducted in Germany. In 4-week run-in controller inhaler was switched to EH+sensor with no change in the drug substance. Salbutamol EH+sensor was used as reliever. Patients in intervention group (IG) received reminders on controller medication use, whereas those in usual care group (UCG) didn’t. Primary end point was controller adherence during last 6 weeks of the 6-month study. <bold>Results:</bold> Patients in IG (N=78) had a significantly higher mean weekly adherence to controller treatment (79.7 %) vs CG (N=80) (58.9%) (p<0.001) with 73% of those in IG vs 40% in UCG having adherence of > 80% (p<0.001). Difference emerged in the first month and remained for the rest of the study (Figure 1). Mean weekly reliever use was less in IG vs UCG (0.87 vs 1.93 inhalations, p<0.05). <bold>Conclusions:</bold> Inhaler treatment adherence among patients with asthma may be enhanced by Easyhaler DPI with sensor monitoring and mobile patient feedback. <fig><object-id>erj;64/suppl_68/PA796/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig>

Weizenbaum Institute (DE), KUKA (Germany) (DE), Keskuslaboratorio (FI), Hamburg Institute for Therapy Research (DE), IFT Institut für Therapieforschung (DE), Gauss Centre for Supercomputing (DE), Praxis (EE)
Openalex Percentile: Top 72%
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.